Skip to content
Review

FABPs-mediated lipid signaling pathways in tumor reprogramming: bidirectional crosstalk with the immune microenvironment.

Sep 2026 · Bioorganic chemistry (Print) · Vol 182, pp. 110484 · 0 citations · 136 references
Medicine

TL;DR

This review emphasizes multi-isoform FABP-mediated lipid metabolic crosstalk across tumor and immune-cell compartments, highlighting reciprocal TME regulation, immune-cell dysfunction, and therapeutic responsiveness.

Abstract

Fatty acid-binding proteins (FABPs) are cytoplasmic lipid chaperones that regulate intracellular fatty acid trafficking and metabolic homeostasis. Increasing evidence identifies FABPs as key drivers of tumor metabolic reprogramming. Within the broader tumor microenvironment (TME), particularly its immune compartment, the tumor immune microenvironment (TIME), FABP isoforms coordinate lipid uptake, synthesis, oxidation, and storage, thereby supporting tumor growth and metastatic progression. Beyond tumor cells, FABP-dependent lipid remodeling shapes immune cell function and tumor-immune crosstalk by modulating lipid availability and redox balance. Conversely, tumor-microenvironmental cues, including adipocyte-derived lipids, obesity-associated fatty acids, macrophage polarization signals, and immune-checkpoint signaling, can regulate FABP expression and redistribute lipid metabolic programs among tumor and immune cells. Given their central function in lipid metabolic networks, FABPs represent promising therapeutic targets. Unlike previous FABP4-centered reviews, this review emphasizes multi-isoform FABP-mediated lipid metabolic crosstalk across tumor and immune-cell compartments, highlighting reciprocal TME regulation, immune-cell dysfunction, and therapeutic responsiveness.

View source

Similar papers

Review Open access Sep 2026

Immunometabolic programming of macrophages and tumor-associated macrophages: metabolic pathways shaping polarization, immune regulation, and disease outcomes

This review integrates core macrophage immunometabolic pathways with TAM biology, emphasizing how lactate accumulation, altered lipid mediators, cholesterol remodeling, and amino acid dependencies reshape macrophage states and suppress antitumor immunity through checkpoint signaling and metabolic deprivation.

Jia-Wei He, Bo-Wen Wang, En-Ze Lei et al. · 0 citations
Review Open access Nov 2026

RNA-binding proteins in tumor lipid metabolic reprogramming: from mechanistic understanding to targeted therapy

Dysregulation of lipid metabolism is a central hallmark of tumor cells, providing not only the energy reserves necessary for rapid proliferation but also the structural precursors required for membrane biosynthesis. RNA-binding proteins (RBPs), as central executors of post-transcriptional regulation, play an increasing...

Xiao-Rui Zhang, Y. Piao, Jin-Shan Zhang et al. · 0 citations
Open access Oct 2026

FABP4 Couples Lipid Metabolism to PD-L1 Stabilization in Immunosuppressive Myeloid Cells.

Metabolic dysregulation in obesity reshapes immune function, but how lipid signals drive immune suppression remains unclear. Herein, we identify a FABP4-PD-L1 axis that links lipid metabolism to immune checkpoint regulation in myeloid cells. Single-cell transcriptomics revealed a distinct FABP4high immunosuppressive sp...

Jian-Yu Yu, Jonathan S. Shilyansky, J. Hao et al. · 0 citations
Review Oct 2026

Circular RNAs in Breast Cancer Immunometabolism: Mechanisms of Immune Regulation and Metabolic Reprogramming.

Metabolic reprogramming and immune dysfunction are increasingly recognized as interconnected hallmarks of breast cancer progression, collectively shaping tumor evolution, immune evasion, and therapeutic response. Emerging evidence identifies circular RNAs (circRNAs), a highly stable class of endogenous non-coding RNAs...

Hai-Liang Jing, J. Jian, Chen Xing et al. · 0 citations
Review Open access Nov 2026

Nanomaterial-Mediated Metabolic Modulation of Immune Responses: Mechanisms and Therapeutic Perspectives

Abstract Dysregulated immune responses drive the onset and progression of inflammatory, autoimmune, and metabolic diseases. Emerging evidence identifies cellular metabolism as a central regulatory hub of immune responses, where it not only meets the bioenergetic and biosynthetic demands of immune cells but also generat...

Hong-Yan Zhang, Bi-Chong Luo, Hui-Min Tao et al. · 0 citations
Sep 2026

MCM10 Modulates Lipid Metabolic Reprogramming via the USP7-FASN Axis to Accelerate Renal Cell Carcinoma Progression.

Metabolic reprogramming, particularly dysregulated lipid metabolism, is a hallmark of clear cell renal cell carcinoma (ccRCC) progression. However, the upstream regulators responsible for lipid metabolic rewiring remain largely unknown. Here, we integrated single-cell RNA sequencing, spatial transcriptomics, and functi...

Ashuai Du, Ke-Hua Jiang, Kai Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.